Review our commercial product billing guide
Dec. 2023Important Notices
Pennsylvania Act 1 of 2023, signed into law this May, requires insurance policies to cover all costs associated with one supplemental breast screening every year for women with increased risk of breast cancer via MRI or ultrasound.
To assist providers in navigating this new law, we are offering recommendations as a guide to aid with compliance.
We encourage you to review our commercial product billing guide for recommendations around complying with Pennsylvania Act 1 of 2023.
If you have any questions or concerns, please contact your physician account executive or call Provider Services at 1-866-918-1595.
To assist providers in navigating this new law, we are offering recommendations as a guide to aid with compliance.
We encourage you to review our commercial product billing guide for recommendations around complying with Pennsylvania Act 1 of 2023.
If you have any questions or concerns, please contact your physician account executive or call Provider Services at 1-866-918-1595.
Recent Announcements
Medicaid Renewal
Starting in 2027, some Medicaid recipients (ages 19–-64) will have new requirements to keep their coverage.Aug. 2026Important Notices
Provider Directory Updates and Required Attestation
As you know, UPMC Health Plan requires all providers to verify their provider directory information at least every 90 days (quarterly).Aug. 2026Important Notices
Voluntary nationwide recall: Tyenne (Fresenius – August 2026)
Fresenius Kabi is recalling one lot, lot 16UI07, of Tyenne® (tocilizumab-aazg) Injection 400 mg/20 mL (20 mg/mL) 20 mL vials. Tyenne is used for the treatment of certain arthritis conditions.Aug. 2026Pharmacy Updates